Precision Medicine Market – Analysis and Forecast (2017-2026)

© 2017 BIS Research, All Copyrights Reserved
Global Precision Medicine Market –Analysis and Forecast (2017-2026)
Global Precision Medicine Market –Analysis and
Forecast (2017-2026)
(Focus on Ecosystem Player, Technology, Therapeutic Applications, Patent Landscape, Country
Analysis, R&D Pipeline, Product Mapping, Market Share Analysis and Competitive Insights)

BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-depth market
intelligence reports focusing on the market estimations, technology analysis, emerging high-growth applications, deeply
segmented granular country-level market data and other important market parameters useful in the strategic decision
making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom
research services.
Copyright © 2017 BIS Research
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research.
Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly
prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It
may not be accessed by, or offered whether for sale or otherwise to any third party.
2

SR.
NO
CONTENTS
Executive Summary
1 Report Scope & Methodology
1.1 Scope of the Report
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Primary Research
1.3.2 Secondary Research
1.3.3 Data Triangulation
1.3.4 Key Data Points from Primary Sources
1.3.5 Key Data Points from Secondary Sources
1.3.6 Top-Down Approach (Segmental Analysis)
1.3.7 Bottom-Up Approach (Segmental Analysis)
1.5 Assumptions and Limitations
2 Market Overview
2.1 Introduction
2.2 Precision Medicine Approach
2.3 Evolution of Precision Medicine Technology
2.4 Precision Medicine: Areas of Interest
2.5 Initiatives and Programs
3 Market Dynamics
3.1 Overview
Table of Content
3

SR.
NO
CONTENTS
3.2 Impact Analysis
3.3 Drivers
3.4 Restraints
3.5 Opportunities
4 Competitive Insights
4.1 Share of Key Development and Strategies
4.2 Product Pipeline Analysis
4.3 Market Share Analysis
4.4 Industry Attractiveness
4.4.1 Definition of Suppliers and Buyers in Precision Medicine Market
4.4.2 Bargaining Power of Suppliers
4.4.3 Bargaining Power of Buyers
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitute Products
4.4.6 Intensity of Competitive Rivalry
4.5 Supply Chain Analysis
5 Industry Insights
5.1 Patent Analysis
5.2 Legal Requirements and Regulations
5.3 Role of FDA in Advancing Precision Medicine
6 Global Precision Medicine Market, by Ecosystem Players
Table of Content
4

SR.
NO
CONTENTS
6.1 Overview
6.2 Pharmaceutical and Biotechnology Companies
6.2.1 Role of Pharmaceutical and Biotechnology Companies
6.2.2 Drug Development Process
6.2.3 Examples of Some Precision Medicine Drugs
6.2.4 Drivers and challenges
6.2.5 Recent Key Developments
6.3 Diagnostic Companies and Clinical Research Laboratories
6.3.2 Diagnostic Tests Benefits for Stakeholders
6.4 Healthcare IT/ Big Data Companies
6.4.1 Benefits of Big Data
6.4.3 Basic Ingredients Provide by Big Data for Precision Medicine
7 Global Precision Medicine Market, by Technology
7.1 Overview
7.2 Role of Biomarker Based Test
7.3 Companion Diagnostics
7.3.1 Drug and Companion Diagnostics Development Process
Table of Content
5

SR.
NO
CONTENTS
7.4 Bioinformatics
7.5 Big Data Analytics
7.6 Gene Sequencing
7.6.1 Sequencing Technologies in Precision Medicine
7.7 Pharmacogenomics
7.7.1 Clinical Applications of Pharmacogenomics Testing
7.7.2 Role of FDA in Pharmacogenomics
7.8 Molecular Diagnostics
7.9 Others
7.9.1 Consumer Genomics
7.9.2 3D Printing
7.9.3 Prosthetic Market
7.9.4 Human tissues Market
8 Global Precision Medicine Market, by Therapeutic Application
8.1 Overview
8.2 Oncology
8.2.1 Types of Cancer
Table of Content
6

SR.
NO
CONTENTS
8.2.2 Government Initiatives
8.3 Cardiovascular
8.4 Central Nervous System
8.5 Infectious Diseases
8.6 Immunology
8.7 Others
9 Global Precision Medicine Market, by Region
9.1 Overview
9.2 Key Insights
9.3 North America
9.3.1 Market Scope
9.3.2 North America: Market Insights and Statistics
9.3.3 North America: by Country
9.3.4 North America: by Ecosystem Players
9.3.5 North America: by Technology
9.3.6 North America: by Therapeutic Applications
9.3.7 North America: Market Dynamics
9.3.8 Key Regulatory Bodies and Associations
Table of Content
7

SR. NO CONTENTS
9.3.9 The U.S.
9.3.9.1 The U.S.: by Ecosystem Players
9.3.9.2 The U.S.: by Technology
9.3.9.3 The U.S.: by Therapeutic Applications
9.3.10 Canada
9.3.7 Key Market Players in North America
9.3.8 North America: Recent Key Developments
9.4 Europe
9.4.1 Market Scope
9.4.2 Europe: Market Insights and Statistics
9.4.3 Europe: by Country
9.4.4 Europe: by Ecosystem Players
9.4.5 Europe: by Technology
9.4.6 Europe: by Therapeutic Applications
9.4.7 Europe: Market Dynamics
9.4.8 Germany
9.4.9 The U.K.
9.4.10 France
9.4.11 Italy
9.4.12 Spain
9.4.13 Rest of Europe
9.4.14 Key Market Players in Europe
Table of Content
8

SR. NO CONTENTS
9.4.15 Europe: Recent Key Developments
9.5 Asia Pacific
9.5.1 Market Scope
9.5.2 Asia Pacific: Market Insights and Statistics
9.5.3 Asia Pacific: by Country
9.5.4 Asia Pacific: by Ecosystem Players
9.5.5 Asia Pacific: by Technology
9.5.6 Asia Pacific: by Therapeutic Applications
9.5.7 Asia Pacific: Market Dynamics
9.5.8 China
9.5.9 Japan
9.5.10 India
9.5.11 Australia
9.5.12 Rest of Asia Pacific
9.5.13 Key Market Players in Asia Pacific
9.6 Rest of the World
9.6.1 Rest of the World: Market Insights and Statistics
9.6.2 Rest of the World: by Ecosystem Players
9.6.3 Rest of the World by Technology
9.6.4 Rest of the World: by Therapeutic Applications
9.6.5 Asia Pacific: Market Dynamics
9.6.6 Middle East Africa
Table of Content
9

SR.
NO
CONTENTS
9.6.7 Latin America
9.6.8 Rest of the World: Recent Key Developments
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Product Portfolio
10.1.3 Financials
10.1.3.1 Financial Summary
10.1.4 SWOT Analysis
10.2 Almac Group
10.2.1 Overview
10.2.3 Financials
10.3 Amgen, Inc.
10.3.1 Overview
10.3.3 Financials
Table of Content
10

SR.
NO
CONTENTS
10.4 ANGLE plc
10.4.1 Overview
10.4.2 Financials
10.5 Astellas Pharma, Inc.
10.5.1 Overview
10.5.3 Financials
10.6 AstraZeneca PLC
10.6.1 Overview
10.6.3 Financials
10.7 ASURAGEN, INC.
10.7.1 Overview
10.7.3 Corporate Summary
Table of Content
11

SR.
NO
CONTENTS
10.8 Bio-Rad Laboratories, Inc.
10.8.1 Overview
10.8.3 Financials
10.9 bioMérieux SA
10.9.1 Overview
10.9.2 Financials
10.10 BRISTOL-MYERS SQUIBB COMPANY
10.10.1 Overview
10.10.3 Financials
10.11 CETICS Healthcare Technologies GmbH
10.11.1 Overview
Table of Content
12

SR. NO CONTENTS
10.12 Danaher Corporation
10.12.1 Overview
10.12.3 Financials
10.13 Eli Lilly and Company
10.13.1 Overview
10.13.3 Financials
10.14 Epic Sciences, Inc.
10.14.1 Overview
10.15 F.Hoffmann-La Roche AG
10.15.1 Overview
10.15.3 Financials
Table of Content
13

SR. NO CONTENTS
10.16 GE Corporation
10.16.1 Overview
10.16.3 Financials
10.17 Gilead Sciences, Inc.
10.17.1 Overview
10.17.3 Financials
10.18 GlaxoSmithKline Plc
10.18.1 Overview
10.18.3 Financials
10.19 IBM Corporation
10.19.1 Overview
Table of Content
14

SR. NO CONTENTS
10.19.3 Financials
10.20 Illumina, Inc.
10.20.1 Overview
10.20.3 Financials
10.21 Intomics A/S
10.21.1 Overview
10.22 JOHNSON & JOHNSON
10.22.1 Overview
10.22.3 Financials
10.23 Laboratory Corporation of America
10.23.1 Overview
Table of Content
15

SR. NO CONTENTS
10.23.3 Financials
10.24 MDX Health, Inc.
10.24.1 Overview
10.24.2 Financials
10.25 Menarini Silicon Biosystems, Inc.
10.25.1 Overview
10.26 KGaA
10.26.1 Overview
10.26.2 Financials
10.27 Myriad Genetics, Inc.
10.27.1 Overview
Table of Content
16

SR. NO CONTENTS
10.27.3 Financials
10.28 Novartis AG
10.28.1 Overview
10.28.3 Financials
10.29 Oracle
10.29.1 Overview
10.29.3 Financials
10.30 Pacific Biosciences of California, Inc.
10.30.1 Overview
10.30.4 Financials
10.31 Partek, Inc.
10.31.1 Overview
Table of Content
17

SR. NO CONTENTS
10.32 Pfizer, Inc.
10.32.1 Overview
10.32.3 Financials
10.33 QIAGEN
10.33.1 Overview
10.33.3 Financials
10.34 Quest Diagnostics
10.34.1 Overview
10.34.3 Financials
10.35 Randox Laboratories
Table of Content
18

SR. NO CONTENTS
10.35.1 Overview
10.36 SANOFI
10.36.1 Overview
10.36.3 Financials
10.37 Sysmex Corporation
10.37.1 Overview
10.37.3 Financials
10.38 Teva Pharmaceuticals Industries Limited.
10.38.1 Overview
10.38.3 Financials
Table of Content
19

SR. NO CONTENTS
10.39 Thermo Fisher Scientific
10.39.1 Overview
10.39.3 Financials
10.40 TROVAGENE, INC.
10.40.1 Overview
10.40.3 Financials
10.41 Snapshot of Some Key Companies
I. Annexure 1: List of Precision Medicine Drugs
II. Annexure 2: Recent Key Developments (2012-2017)
III. Annexure 3: Patent Landscape and Regulatory Body Lists
IV. Annexure 4: Product Mapping
V. Annexure 5: Cancer Incidence Data Sheet
Table of Content
20

SR.
NO
LIST OF TABLES
1 Initiatives and Programs in Precision Medicine
2 Security Breachment Cases/ Developments (2011-2015)
3 Cost of Genome Sequencing
4 Competitive Landscape: Some of The Key Players
5 Regulatory Bodies In Precision Medicine
6 Consortiums in the Precision Medicine Market
7 Alliance/Associations in the Precision Medicine Market
8 Global Pharma & Biotech Companies Precision Medicine Market, by Therapeutic Application, ($Billion)
9 Example of Some Precision Medicine Drugs
10 Biotechnology and Pharmaceutical Companies- Recent Key Developments
11 Global Diagnostic Tool Companies Precision Medicine Market, by Therapeutic Application, ($Billion)
12 Diagnostic Test Companies- Recent Key Developments
13 Global Healthcare IT/ Big Data Companies Precision Medicine Market, by Therapeutic Application, ($Billion)
14 Service Providers- Recent Developments
15 Global Precision Medicine Market Value, by Technology Types ($Billion)
16 List of Biobanking Initiatives Across Selected OECD Countries
17 Global Precision Medicine Market Value, by Therapeutic Applications ($Billion)
18 Global Precision Medicine Market Value, by Region ($Billion)
21 Next Generation Sequencing- Recent Key Developments
21
List of Tables

SR.
NO
LIST OF TABLES
22 List of Biobanks
25 Companion Diagnostics- Recent Key Developments
26 List of FDA Approved Companion diagnostics
28 List of Few FDA Approved Pharmacogenomics Biomarkers in Drug Labelling
30 List of Few Human Genetic Tests Approved by FDA
31 List of Few Microbial Tests Approved by FDA
32 Others Molecular Diagnostics : List of Human Genetic Tests
34 Global Precision Medicine Market Value, by Technology ($Billion)
35 Cancer Precision Medicine Drugs and Indications
36 Oncology- Recent Developments
38 Cardiovascular Precision Medicine Drugs/Tests/ and Indications
40 Central Nervous System Precision Medicine Drugs and Indications
42 Infectious Diseases Precision Medicine Drugs and Indications
22
List of Tables

SR.
NO
LIST OF TABLES
45 Other Diseases: Examples of Some Drugs
46 Recent Key Developments
47 North America Precision Medicine Market, by Technology ($Billion)
48 North America Precision Medicine Market, by Therapeutic Application ($Billion)
49 Key Market Players in North America
50 North American precision medicine Market Recent Key Developments
51 Europe Precision Medicine Market, by Technology ($Billion)
52 Europe Precision Medicine Market, by Therapeutic Application ($Billion)
53 Key Market Players in Europe
54 Europe: Recent Key Developments
55 Asia Pacific (APAC) Precision Medicine Market, by Technology ($Billion)
56 Asia Pacific (APAC) Precision Medicine Market, by Therapeutic Applications ($Billion)
57 Key Market Players in Asia Pacific
58 Rest of the World (RoW) Precision Medicine Market, by Technology ($Billion)
59 Rest of the World (RoW) Precision Medicine Market, by Therapeutic Application ($Billion)
60 Recent Key Developments
23
List of Tables

SR.
NO
LIST OF FIGURES
1 Chronic Conditions: Key Statistics: 2016
2 Long-Term Growth Drivers
3 Global Precision Medicine Market
4 Strategies Incorporated to Expand the Global Reach
5 Global Precision Medicine Market, by Therapeutic Application, 2016 and 2026
6 Global Precision Medicine Market, by Technology, 2016 and 2026
7 Global Precision Medicine Market, by Region, 2016 and 2026
8 Global Precision Medicine Market Segmentation
9 Year Consideration
10 Share of Key Developments and Strategies
11 Market Share Analysis
12 Porter’s Five Forces Analysis
13 Supply Chain Analysis
14 Patent Analysis
15 Ecosystem Players in Precision Medicine
16 Global Precision Medicine Market Value, by Ecosystem Players ($Billion)
17 Global Pharma & Biotech Companies Precision Medicine Market Value, by Region ($Billion)
18 Role of Pharmaceuticals And Biotech Companies
19 Drug Development Process
20 Pharmaceutical Companies- Drivers and Challenges
21 Global Diagnostic Tool Companies Precision Medicine Market Value, by Region ($Billion)
24
List of Figures

SR.
NO
LIST OF FIGURES
22 Diagnostic Companies: Drivers and Challenges
23 Diagnostic Tests Benefits for Stakeholders
24 Global Healthcare IT / Big Data Companies Precision Medicine Market Value, by Region ($Billion)
25 Three Data Drivers of the Precision Medicine Market
26 Benefits of Big Data
27 Big Data Companies: Drivers and Challenges
28 Transformation of Medicine
29 Basic Ingredients Provided By Big Data for Precision Medicine
30 Key Players
31 Technologies in Precision Medicine
32 Functions of Biomarkers
33 Biomarker Services
34 Biomarkers-List of Biobanks
35 Biomarker Market Dynamics
36 Biomarkers-Recent Key Developments
37 Sequencing Technologies in precision medicine
38 Next Generation Sequencing: Drivers and Challenges
39 Sequencing Applications
42 Drug And Companion Diagnostics Development Process
25
List of Figures

SR.
NO
LIST OF FIGURES
43 Companion Diagnostics: Market Dynamics
45 Clinical Applications of Pharmacogenomics Testing
46 Mechanism of Action
47 Role of FDA in Pharmacogenomics
49 Types of Molecular Diagnostics Tests
51 Therapeutic Areas in Precision Medicine
52 Global Precision Medicine Market, by Application, 2016 and 2026 ($Billion)
53 Global Precision Medicine Market Value, By Ecosystem Players ($Billion)
55 Types of Cancer
56 Government Initiatives
57 Cancer related Some Important Facts
58 Oncology: Market Dynamics
26
List of Figures

SR.
NO
LIST OF FIGURES
70 North America Precision Medicine Market, By Region, 2015-2022 ($BILLION)
71 North America Precision Medicine Market, by Ecosystem Players, 2015-2022 ($BILLION)
72 North America Precision Medicine Market, by Therapeutic Applications, 2015-2022 ($BILLION)
73 North America: Market Dynamics
74 Key regulatory Bodies and Associations
75 North America Precision Medicine Market, ($Billion)
76 North America Precision Medicine Market, by Ecosystem Players, ($Billion)
77 The U.S. Precision Medicine Market ($Billion)
78 The U.S. Precision Medicine Market, by Ecosystem Players ($Billion)
79 The U.S. Precision Medicine Market, by Technology ($Billion)
80 The U.S. Precision Medicine Market, by Therapeutic Applications ($Billion)
81 Objectives of The Precision Medicine Initiative
82 Canada Precision Medicine Market ($Billion)
83 Canada: Market Dynamics
84 Europe Precision Medicine Market, ($Billion)
27
List of Figures

SR.
NO
LIST OF FIGURES
85 Europe Precision Medicine Market, by Region ($Billion)
86 Europe Precision Medicine Market, by Ecosystem Players ($Billion)
87 Europe Precision Medicine Market, by Technology ($Billion)
88 Europe Precision Medicine Market, by Therapeutic Applications ($Billion)
89 Europe: Market Dynamics
90 Asia-Pacific (APAC) Precision Medicine Market, ($Billion)
91 Asia Pacific (APAC) Precision Medicine Market, by Region ($Billion)
92 Asia Pacific (APAC) Precision Medicine Market, by Ecosystem Players, ($Billion)
93 Asia Pacific (APAC) Precision Medicine Market, by Technology ($Billion)
94 Asia Pacific (APAC) Precision Medicine Market, by Therapeutic Applications ($Billion)
95 Asia Pacific: Market Dynamics
96 China: Market Dynamics
97 India: Market Dynamics
98 Rest of the World (RoW) Precision Medicine Market, ($Billion)
99 Rest of the World (RoW)Precision Medicine Market, by Region ($Billion)
100 Rest of the World (RoW) Precision Medicine Market, by Ecosystem Players, ($Billion)
101 Rest of the World (RoW) Precision Medicine Market, by Technology ($Billion)
102 Rest of the World (RoW) Precision Medicine Market, by Therapeutic Applications ($Billion)
103 Middle East: Market Dynamics
104 Examples of some of the programs helping in the Growth of Precision Medicine Market
105 South America: Market Dynamics
28
List of Figures

SR.
NO
LIST OF FIGURES
106 Africa: Market Dynamics
107 Abbott Laboratories- Product Areas
108 Abbott Laboratories-Product Mapping
109 Abbott Laboratories- Overall Financials (2014-2016)
110 Abbott Laboratories- Net Revenue by Business Segment(2014-2016)
111 Abbott Laboratories - Net Revenue by Region (2014-2016)
112 Abbott Laboratories-SWOT Analysis
113 Almac Group- Product Mapping
114 Almac Group- SWOT Analysis
115 Amgen, Inc.-Product Mapping
116 Amgen, Inc. - Overall Financials (2014-2016)
117 Amgen, Inc.- Net Sales by Geographic Destination (2014-2016)
118 Amgen, Inc.-SWOT Analysis
119 ANGLE plc- Overall Financials (2014-2016)
120 ANGLE plc- Net Revenue by Region (2016)
121 Astellas Pharma, Inc.-Product Mapping
122 Astellas Pharma, Inc. - Overall Financials (2014-2016)
123 Astellas Pharma, Inc.- Net Sales by Product Type (2014-2016)
124 Astellas Pharma, Inc.- Net Sales by Geographic Destination (2014-2016)
125 Astellas Pharma, Inc.-SWOT Analysis
126 AstraZeneca PLC-Product Mapping
29
List of Figures

SR.
NO
LIST OF FIGURES
127 AstraZeneca PLC -Overall Financials ( 2014-2016)
128 AstraZeneca PLC- Net Revenue by Business Segment (2014-2016)
129 AstraZeneca PLC- Revenue across Different Geographies( 2014-2016)
130 AstraZeneca PLC-SWOT Analysis
131 ASURAGEN, INC.-Product Mapping
132 ASURAGEN, INC.-SWOT Analysis
133 Bio-Rad Laboratories, Inc. -Product Mapping
134 Bio-Rad Laboratories, Inc. -Overall Financials ( 2014-2016)
135 Bio-Rad Laboratories, Inc. - Net Revenue by Business Segment(2014-2016)
136 Bio-Rad Laboratories, Inc. - Revenue by Region( 2014-2016)
137 Bio-Rad Laboratories, Inc.-SWOT Analysis
138 bioMérieux SA- Overall Financials(2014-2016)
139 bioMérieux SA- Net revenue share by Business Segment (2014-2016)
140 bioMérieux SA- Net revenue share by Geography(2014-2016)
141 bioMérieux SA-SWOT Analysis
142 BRISTOL-MYERS SQUIBB COMPANY -Product Mapping
143 BRISTOL-MYERS SQUIBB COMPANY- Overall Financials (2014-2016
144 BRISTOL-MYERS SQUIBB COMPANY- Net Sales by Product Type (2014-2016)
145 BRISTOL-MYERS SQUIBB COMPANY- Net Sales by Geographic Destination (2014-2016)
146 BRISTOL-MYERS SQUIBB COMPANY-SWOT Analysis
147 CETICS Healthcare Technologies GmbH -Product Mapping
30
List of Figures

SR.
NO
LIST OF FIGURES
148 CETICS Healthcare Technologies GmbH -SWOT Analysis
149 Danaher Corporation -Product Mapping
150 Danaher Corporation- Overall Financials(2014-2016)
151 Danaher Corporation- Net revenue share by Business Segments(2014-2016)
152 Danaher Corporation- Net revenue share by Geography, (2014-2016)
153 Danaher Corporation-SWOT Analysis
154 Elli-Lilly and Company -Product Mapping
155 Eli Lilly and Company - Overall Financials (2014-2016)
156 Eli Lilly and Company - Net Sales by Product Type (2014-2016)
157 Eli Lilly and Company- Net Sales by Geographic Destination (2014-2016)
158 Eli Lilly and Company-SWOT Analysis
159 Epic Sciences, Inc. -SWOT Analysis
160 F.Hoffmann-La Roche AG -Product Mapping
161 Roche AG: Net Revenue(2014-2016)
162 Roche AG- Revenue By Divisions (2014-2016)
163 Roche AG-Revenue By Diagnostics Sub-division (2013-2016)
164 Roche AG- Revenue By Geographical Area (2014-2016)
165 F.Hoffmann-La Roche AG-SWOT Analysis
166 GE Healthcare -Product Mapping
167 GE Corporation-Overall Financials (2014-2016)
168 GE Corporation- Net Revenue by Business Segments (2014-2016)
31
List of Figures

SR.
NO
LIST OF FIGURES
169 GE Corporation- Net Revenue by Geography (2014-2016)
170 Percentage of Revenues by Healthcare Sub Segments - 2016
171 GE Healthcare-SWOT Analysis
172 Gilead Sciences, Inc. -Product Mapping
173 Gilead Sciences, Inc.- Overall Financials (2014-2016)
174 Gilead Sciences, Inc.- Revenue Across Different Geographies(2014-2016)
175 Gilead Sciences, Inc.-SWOT Analysis
176 GlaxoSmithKline Plc -Product Mapping
177 GlaxoSmithKline: Overall Financials (2013-2016)
178 GlaxoSmithKline- Net Revenue by Business Segments (2013-2016)
179 GlaxoSmithKline- Net Revenue by Geography (2013-2015)
180 GlaxoSmithKline-Net Revenue by Geography (2016)
181 GlaxoSmithKline-SWOT Analysis
182 IBM Corporation-Product Mapping
183 IBM-Overall Financials (2014-2016)
184 IBM- Net Revenue by Business Segments(2014-2016)
185 IBM-Net Revenue by Geography(2014-2016)
186 IBM Corporation-SWOT Analysis
187 Illumina, Inc.-Product Mapping
188 Illumina, Inc.-Overall Financials(2014-2016)
189 Illumina, Inc.- Net Revenue by Business Segment(2014-2016)
32
List of Figures

SR.
NO
LIST OF FIGURES
190 Illumina, Inc.- Revenue across Different Geographies(2014-2016)
191 Illumina, Inc.-SWOT Analysis
192 Intomics A/S-Product Mapping
193 Intomics A/S-SWOT Analysis
194 Johnson&Johnson-Product Mapping
195 JOHNSON & JOHNSON- Overall Financials(2014-2016)
196 JOHNSON & JOHNSON-Net Revenue By Business Segment(2014-2016)
197 JOHNSON & JOHNSON-Net Revenue By Geography(2014-2016)
198 JOHNSON & JOHNSON- Net Revenue by Medical Devices Business Segment(2014-2016)
199 JOHNSON & JOHNSON- Net Revenue by Orthopedic Sub segment(2014-2016)
200 JOHNSON & JOHNSON-SWOT Analysis
201 Laboratory Corporation of America-Product Mapping
202 Laboratory corporation of America-Overall Financials (2014-2016)
203 Laboratory Corporation of America- Net Revenue by Business Segments(2014-2016)
204 Laboratory Corporation of America- Net Revenue by Business Segment and Geography(2014-2016)
205 Laboratory Corporation of America-SWOT Analysis
206 MDX Health, Inc.-Overall Financials (2014-2016)
207 MDX Health, Inc.-SWOT Analysis
208 Menarini Silicon Biosystems, Inc.-Product Mapping
209 Menarini Silicon Biosystems, Inc.-SWOT Analysis
210 Merck & CO., Inc. KGaA- Overall Financials(2014-2016)
33
List of Figures

SR.
NO
LIST OF FIGURES
211 Merck & CO., Inc. KGaA- Net Revenue by Business Segments (2014-2016)
212 Merck & CO., Inc. KGaA-Net Revenue by Geography(2014)
213 Merck & CO., Inc. KGaA- Net Revenue by Geography(2015-2016)
214 Merck & CO., Inc. KGaA, -SWOT Analysis
215 Myriad Genetics, Inc.-Product Mapping
216 Myriad Genetics, Inc.- Overall Financials(2014-2016)
217 Myriad Genetics, Inc.- Net Revenue by Business Segments (2014-2016)
218 Myriad Genetics, Inc. -SWOT Analysis
219 Novartis AG-Product Mapping
220 Novartis AG- Overall Financials (2014-2016)
221 Novartis AG- Net Revenue by Business Segments (2013-2014)
222 Novartis AG- Net Revenue by Business Segments (2015-2016)
223 Novartis AG- Net Revenue by Geography (2013-2016)
224 Novartis AG -SWOT Analysis
225 Oracle-Product Mapping
226 Oracle- Overall Financials (2014-2016)
227 Oracle- Net Revenue by Business Segments (2014-2016)
228 Oracle-Net Revenue by Geography(2014-2016)
229 Oracle -SWOT Analysis
230 Pacific Biosciences of California, Inc.-Product Mapping
231 Pacific Biosciences of California, Inc.- Overall Financials (2014-2016)
34
List of Figures

SR.
NO
LIST OF FIGURES
232 Pacific Biosciences of California, Inc.- Net Revenue by Business Segment (2014-2015)
233 Pacific Biosciences, Inc.- Net Revenue by Business Sub-Segment (2014-2016)
234 Pacific Biosciences of California, Inc.- Net Revenue by Region (2014-2015)
235 Pacific Biosciences of California, Inc.-SWOT Analysis
236 Partek, Inc.-Product Mapping
237 Partek, Inc.-SWOT Analysis
238 Pfizer, Inc.-Product Mapping
239 Pfizer- Overall Financials (2013-2016)
240 Pfizer- Net Revenue by Geography (2013-2016)
241 Pfizer- Net Revenue by Business Segments (2013-2014)
242 Pfizer- Net Revenue by Business Segments (2015-2016)
243 Pfizer, Inc.-SWOT Analysis
244 QIAGEN-Product Mapping
245 QIAGEN- Overall Financials (2014-2016)
246 QIAGEN- Net Revenue by Region (2014-2016)
247 QIAGEN-SWOT Analysis
248 Quest Diagnostics-Product Mapping
249 Quest Diagnostics- Overall Financials (2014-2016)
250 Quest Diagnostics- Net Revenue by Business Segments(2014-2016)
251 Quest Diagnostics-SWOT Analysis
252 Randox Laboratories-Product Mapping
35
List of Figures

SR.
NO
LIST OF FIGURES
253 Randox Laboratories-SWOT Analysis
254 SANOFI-Product Mapping
255 SANOFI- Overall Financials (2014-2016)
256 SANOFI: Net Sales by Business Segments (2014-2016)
257 SANOFI- Net Sales by Geographic Destination (2014-2016)
258 SANOFI: Net Sales by Franchise (2014-2016)
259 SANOFI-SWOT Analysis
260 Sysmex Corporation-Product Mapping
261 Sysmex Corporation- Overall Financials (2014-2016)
262 Sysmex Corporation- Revenue by Business Segment (2014-2016)
263 Sysmex Corporation- Revenue by Region(2014-2016)
264 Sysmex Corporation-SWOT Analysis
265 Teva Pharmaceuticals Industries Limited.-Product Mapping
266 Teva Pharmaceuticals Industries Limited.-R&D Pipeline
267 Teva Pharmaceutical Industries Limited- Overall Financials(2013-2016)
268 Teva Pharmaceutical Industries Limited- Net Revenue by Business Segments(2013-2016)
269 Teva Pharmaceutical Industries Limited- Net Revenue by Geography(2013-2016)
270 Teva Pharmaceutical Industries Limited-SWOT Analysis
271 Thermo Fisher Scientific-Product Mapping
272 Thermo Fisher Scientific- Overall Financials (2014-2016)
36
List of Figures

SR.
NO
LIST OF FIGURES
273 Thermo Fisher Scientific- Net Revenue by Business Segment (2014-2016)
274 Thermo Fisher Scientific-Net Revenue by Region (2014-2016)
275 Thermo Fisher Scientific-SWOT Analysis
276 TROVAGENE, INC.-Product Mapping
277 TROVAGENE, INC.-Overall Financials (2014-2016)
278 TROVAGENE, INC.-SWOT Analysis
37
List of Figures

Global Precision Medicine Market –Analysis and Forecast (2017-2026) 38
To know more about us, please visit our website:
bisresearch.com
For sales queries or new topics email us on:
sales@bisresearch.com
For other queries contact:
healthcare@bisresearch.com
THANK YOU
9100 West Bloomington Freeway,
Suite 159 Bloomington,
MN 55431
U.S.
Tel: +1 650 887 7717
BIS Research
9100 West Bloomington Freeway,
Suite 159 Bloomington, MN 55431 U.S.
Tel: +1 650 887 7717
Global Delivery Centre
Tapasya Corp Heights, Subarea,
Sector 126, Noida, NCR-201303 India
Tel: +91 120 4261540 / +91 120 4261544
CONTACT US

Precision Medicine Market – Analysis and Forecast (2017-2026)

Recommended

Recommended

More Related Content

Similar to Precision Medicine Market – Analysis and Forecast (2017-2026)

Similar to Precision Medicine Market – Analysis and Forecast (2017-2026) (20)

More from BIS Research Inc.

More from BIS Research Inc. (20)

Recently uploaded

Recently uploaded (20)

Precision Medicine Market – Analysis and Forecast (2017-2026)